BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23581888)

  • 1. Inhibitory effect of tianeptine on catagen induction in alopecia areata-like lesions induced by ultrasonic wave stress in mice.
    Kim HM; Lim YY; Kim MY; Son IP; Kim DH; Park SR; Seo SK; Lee MS; Mun SK; Kim CW; Kim BJ
    Clin Exp Dermatol; 2013 Oct; 38(7):758-67. PubMed ID: 23581888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles.
    Ito T; Ito N; Saathoff M; Bettermann A; Takigawa M; Paus R
    Br J Dermatol; 2005 Apr; 152(4):623-31. PubMed ID: 15840090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex.
    Lucassen PJ; Fuchs E; Czéh B
    Biol Psychiatry; 2004 Apr; 55(8):789-96. PubMed ID: 15050859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
    Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
    Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
    Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
    Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
    Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated skin mast cells are involved in murine hair follicle regression (catagen).
    Maurer M; Fischer E; Handjiski B; von Stebut E; Algermissen B; Bavandi A; Paus R
    Lab Invest; 1997 Oct; 77(4):319-32. PubMed ID: 9354767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianeptine modulates amygdalar glutamate neurochemistry and synaptic proteins in rats subjected to repeated stress.
    Piroli GG; Reznikov LR; Grillo CA; Hagar JM; Fadel JR; Reagan LP
    Exp Neurol; 2013 Mar; 241():184-93. PubMed ID: 23262120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain.
    Katikaneni R; Gulati R; Suh D; Sakon J; Seymour A; Ponnapakkam T; Gensure R
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S61-2. PubMed ID: 24326563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
    McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
    Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice.
    Zhou X; Guan Z; Jin X; Zhao J; Chen G; Ding J; Ren Y; Zhai X; Zhou Q; Guan Z
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34196345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study.
    Toyoda M; Makino T; Kagoura M; Morohashi M
    Br J Dermatol; 2001 Jan; 144(1):46-54. PubMed ID: 11167682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
    Maurer M; Handjiski B; Paus R
    Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
    Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
    J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.
    McElwee KJ; Boggess D; King LE; Sundberg JP
    J Invest Dermatol; 1998 Nov; 111(5):797-803. PubMed ID: 9804341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.